Global Podophyllin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Podophyllin is a non-alkaloid toxin lignan extracted from the roots and rhizomes of Podophyllum species. Under the trade names Condylox, a gel, and Wartec, a solution or cream, it is used on the skin as a topical treatment of external genital warts, caused by some types of the human papillomavirus (HPV), and other warts. PPT and its synthetic derivatives display a wide selection in medical applications such as purgative, vesicant, antirheumatic, antiviral, and antitumor agents. These derivatives include etoposide and teniposide. Their anticancer activity has been heavily under study and used in various chemotherapies, including lung cancer, lymphomas, and genital tumors

Scope of the Report:
In 2015, the world production of podophyllin reached 2282kg. Globally, podophyllin producers are concentrated in China. Though derived from developed countries in early days, China manufacturers gasped the market of podophyllin soon and dominated the world supply of podophyllin in later years. In 2015, China has taken 54.43% of world podophyllin production. Leading players in China are Haoxiang and Haoxuan, with a tail of other producers. The product related to the podophyllum species distributed in China, USA and India.
The demand of podophyllin is concentrated in developed areas like USA and Ireland. In 2015, the consumption of podophyllin in USA was 32.03%, ahead of other regions. The manufacturing processes of podophyllin: direct extraction method is adopted by manufacturers. Podophyllin produced through direct extract process is directly derived from podophyllum species.
The worldwide market for Podophyllin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Podophyllin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
MP Biomedicals
Perrigo
Himpharm
Haoxiang
Haoxuan
Dajiang
Huahai
Huawei

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
<20% of Podophyllin
20%-50% of Podophyllin
>50% of Podophyllin

Market Segment by Applications, can be divided into
Podophyllotoxin Tincture
Podophyllotoxin Cream
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Podophyllin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Podophyllin, with price, sales, revenue and global market share of Podophyllin in 2017 and 2018.
Chapter 3, the Podophyllin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Podophyllin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Podophyllin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Podophyllin sales channel, distributors, customers, research findings and conclusion, appendix and data source.